Total Return chart Xcell Therapeutics Inc.

Stocks

End-of-day quote Korea S.E. 2026-09-08			5-day change	1st Jan Change
1,017.00 ^KRW	-7.96%		-13.67%	-38.77%

25-08-14	Xcell Therapeutics to conduct capital increase of 15 billion won	RE
24-11-21	Gencurix Inc. announced that it expects to receive KRW 899.999158 million in funding from Xcell Therapeutics Inc.	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.